Back
ProPhase Labs 10K Form
Sell
31
PRPH
ProPhase Labs
Last Price:
2.60
Seasonality Move:
20.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PRPH News And Ratings
See the #1 stock for the next 7 days that we like better than PRPH
PRPH Financial Statistics
Sales & Book Value
| Annual Sales: | $44.38M |
|---|---|
| Cash Flow: | $-4.84M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.31 |
| Price / Book: | 1.06 |
Profitability
| EPS (TTM): | -1.49000 |
|---|---|
| Net Income (TTM): | $-26.31M |
| Gross Margin: | $16.24M |
| Return on Equity: | -51.79% |
| Return on Assets: | -28.7% |
ProPhase Labs Earnings Forecast
Key ProPhase Labs Financial Ratios
- The Gross Profit Margin over the past 27 years for PRPH is 36.59%.
- The Selling, General & Administrative Expenses for PRPH have been equal to 77.74% of Gross Profit Margin.
- The Research & Development expenses have been 3.19% of Revenue.
- The Interest Expense is -7.60% of Operating Income.
- The Net Earning history of PRPH is -37.81% of Total Revenues.
- Per Share Earnings over the last 28 years have been positive in 15 years.
ProPhase Labs Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | PRPH |
| CUSIP: | 74345W |
| Website: | prophaselabs.com |
Debt
| Debt-to-Equity Ratio: | 0.31 |
|---|---|
| Current Ratio: | 1.58 |
| Quick Ratio: | 1.24 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PRPH Technical Analysis vs Fundamental Analysis
Sell
31
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy or a Sell?
-
ProPhase Labs stock is rated a Sell
The current ProPhase Labs [PRPH] share price is $2.45. The Score for PRPH is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.